Steward Partners Investment Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$269K Buy
11,028
+30
+0.3% +$730 ﹤0.01% 1608
2025
Q1
$228K Sell
10,998
-721
-6% -$15K ﹤0.01% 1580
2024
Q4
$276K Sell
11,719
-2,957
-20% -$69.6K ﹤0.01% 1453
2024
Q3
$376K Sell
14,676
-755
-5% -$19.3K ﹤0.01% 1232
2024
Q2
$362K Sell
15,431
-190
-1% -$4.46K ﹤0.01% 1196
2024
Q1
$449K Buy
15,621
+273
+2% +$7.85K 0.01% 1098
2023
Q4
$504K Sell
15,348
-466
-3% -$15.3K 0.01% 1003
2023
Q3
$441K Sell
15,814
-327
-2% -$9.11K 0.01% 968
2023
Q2
$550K Sell
16,141
-216
-1% -$7.36K 0.01% 904
2023
Q1
$492K Buy
16,357
+1,310
+9% +$39.4K 0.01% 932
2022
Q4
$425K Sell
15,047
-4,814
-24% -$136K 0.01% 964
2022
Q3
$653K Buy
19,861
+893
+5% +$29.4K 0.01% 770
2022
Q2
$597K Buy
18,968
+425
+2% +$13.4K 0.01% 798
2022
Q1
$852K Sell
18,543
-5
-0% -$230 0.01% 735
2021
Q4
$1.14M Sell
18,548
-2,775
-13% -$170K 0.02% 654
2021
Q3
$1.59M Buy
21,323
+969
+5% +$72.4K 0.03% 514
2021
Q2
$1.88M Sell
20,354
-19,764
-49% -$1.83M 0.03% 460
2021
Q1
$3.56M Buy
40,118
+7,284
+22% +$646K 0.06% 313
2020
Q4
$3.06M Buy
32,834
+18,461
+128% +$1.72M 0.07% 286
2020
Q3
$916K Buy
14,373
+2,927
+26% +$187K 0.02% 507
2020
Q2
$597K Buy
11,446
+2,389
+26% +$125K 0.02% 576
2020
Q1
$283K Buy
9,057
+1,331
+17% +$41.6K 0.01% 693
2019
Q4
$258K Buy
7,726
+720
+10% +$24K 0.01% 803
2019
Q3
$206K Buy
7,006
+5,456
+352% +$160K 0.01% 837
2019
Q2
$53K Buy
+1,550
New +$53K ﹤0.01% 1312